Latest Ailment Research

image for article
Study: Cannabinoids vs. Chronic Neuropathic Pain
A systematic review published in the Journal of Oral & Facial Pain and Headache found cannabis to be effective in managing chronic neuropathic pain.
image for article
Cannabinoid Treatments vs Triple-Negative Breast Cancer
Studies suggest THC and CBD, the main cannabinoids found in medical marijuana, may help fight and protect against different forms of breast cancer.
image for article
Cannabis-Based Treatments For Multiple Sclerosis
Learn About Effective Cannabis-Based Medicines For Medical Marijuana Patients Living With Multiple Sclerosis
image for article
THC May Help Protect Against Neurodegenerative Diseases
Recent studies show low doses of THC can help treat inflammation in the brain from neurodegenerative diseases like Alzheimer’s and Parkinson’s.
image for article
Cannabinoids Show Potential In Reducing Nausea
A recent Canadian study showed cannabinoids (specifically THCV and CBDV) aided in reducing nausea when treated in 10-20mg doses.
image for article
Study: Cannabidiol as an Effective Asthma Treatment
Researchers at Brazil’s Universidade do Extremo Sul Catarinense conducted a study examining how CBD may effectively manage asthma symptoms in mice.
image for article
An Overview Of Alzheimer's Studies with Cannabis
Studies have shown that medical marijuana may help treat certain alzheimer's symptoms, but doing so must be done with caution.
image for article
Study Shows CBD May Effectively Treat Colon Cancer
In recent studies cannabis extracts high in cannabidiol (CBD) were shown to help prevent the genesis and spread of colon cancer in subjects.
image for article
Cannabidiol (CBD) May Weaken Lung Cancer Cells
German study shows CBD can enhance the susceptibility of lung cancer cells to adhere to and be broken down by lymphokine-activated killer (LAK) cells.
image for article
Marijuana May Reduce Brain Damage Caused By Strokes
A meta-analysis of studies shows the amount of the brain injured from a stroke was reduced in subjects that had used cannabinoid therapies.